We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Tetrahydrocurcumin (THC, a curcumin metabolite)
The main active metabolite of curcumin, sold as a colourless, more stable 'next-generation curcumin.' It's a genuine antioxidant and anti-inflammatory in the lab, but human evidence is almost non-existent — experimental, not a proven supplement.
What the evidence says
Most Tetrahydrocurcumin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 2006–2026 with a typical study size of 19 participants.
Based on 21 studies · 1 RCT · 29 total participants
Confidence
Low confidenceBy outcome
5 more outcomes with fewer studies not shown.
Extensive, consistent preclinical evidence for antioxidant and anti-inflammatory activity across cell and animal models, but almost no human data — one 19-person open-label antidepressant-adjunct pilot and one small non-significant topical vitiligo study. No RCTs powered for clinical outcomes, and the one head-to-head review finds curcumin acts on far more molecular targets. Scored Emerging.
Tetrahydrocurcumin (THC) is what the body makes when it reduces curcumin — the main coloured compound in turmeric. It's colourless, more water-stable than curcumin, and in many cell and animal studies shows antioxidant, anti-inflammatory, and metabolic activity through pathways like NF-κB, Nrf2, and AMPK.
Supplement marketers frame it as a 'more bioavailable, next-generation curcumin.' The honest picture is much more cautious: the vast majority of evidence is preclinical (test tubes and rodents), and a head-to-head review found curcumin binds and inhibits far more molecular targets, while THC is stronger for some antioxidant actions.
THC is not simply 'better curcumin.' Direct human data amounts to a single tiny open-label pilot (19 people) in which adding it to an antidepressant did not change total depression scores, and one small topical study for vitiligo that did not reach statistical significance.
Until real randomized trials exist, THC is best understood as a promising but experimental supplement rather than one with demonstrated benefits.
Scavenges reactive oxygen species and induces antioxidant enzymes (e.g. glutathione peroxidase) in cell and animal models. A head-to-head review found THC was often the stronger antioxidant, while curcumin acts on far more molecular targets.
Downregulates NF-κB signalling and inflammatory cytokines (TNF-α, IL-1β) in preclinical inflammation models.
Activates the Nrf2 pathway and modulates MAPK, PI3K/Akt/mTOR, and AMPK signalling in laboratory studies — the basis for most of its proposed metabolic and organ-protective effects.
THC is the reduced, colourless metabolite the body forms from curcumin. It is more water-stable, which is the rationale behind marketing it as a 'more bioavailable' alternative — a claim not yet validated by human pharmacokinetic outcomes.
How Tetrahydrocurcumin works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Avoid — no safety data.
Discuss with a clinician before use given the theoretical antiplatelet effect of curcuminoids.
Prefer standardised curcumin, which has far more human evidence than THC.
THC-specific data are preclinical only: THC reduced platelet activation in human platelets in vitro and slowed thrombus growth in mice without prolonging bleeding time, and did not add to aspirin's effect on thrombosis (PMID 34428833). No human bleeding data exist, so an additive bleeding risk with warfarin, clopidogrel or aspirin remains theoretical.
Preclinical glucose-lowering activity raises a theoretical additive risk with diabetes medications; unquantified in humans.
Curcuminoids can modulate drug-metabolising enzymes and transporters, potentially altering levels of some medications. THC-specific relevance is unknown.
Tip: Take with food; reduce dose
Tip: Human safety beyond short pilots is uncharacterised — use conservatively
The current evidence for Tetrahydrocurcumin is insufficient to assign an evidence score, based on 21 indexed studies. The main active metabolite of curcumin, sold as a colourless, more stable 'next-generation curcumin.' It's a genuine antioxidant and anti-inflammatory in the lab, but human evidence is almost non-existent — experimental, not a proven supplement. Representative study: PMID 42281524.
Dosing for Tetrahydrocurcumin: No established human dose. The one oral human pilot used 200 mg/day; supplement products typically supply 250–500 mg/day. Dosing is not evidence-based. Individual needs vary, so check the right dose for you with a healthcare provider.
Timing is flexible for Tetrahydrocurcumin — consistent daily use matters more than the time of day. As a lipophilic curcumin-type compound, taking it with a fat-containing meal is a reasonable default for absorption, but no human timing data exist.
Tetrahydrocurcumin has a safety rating of "moderate". That is a category, not a measure of individual risk, and there are precautions worth knowing. Reported side effects include unknown long-term effects, GI upset. How often they occur is not established for all of them. Use caution if any of these apply to you: Pregnancy and breastfeeding (no safety data); Bleeding disorders or scheduled surgery (theoretical antiplatelet effect, by analogy to curcumin).
Smoking status: not checked. Beta-Carotene: what these mean for you changes depending on whether you smoke or used to, and you have not told us. That check was skipped.
Huperzine A
Too few graded studiesAcetylcholinesterase inhibitor from club moss, studied mainly for Alzheimer's and dementia; cognitive evidence is mixed and limited by trial quality.
Beta-Carotene
Too few graded studiesA plant pigment the body converts to vitamin A, sold for "natural tanning". It does not tan you — at high doses it turns skin orange-yellow. In smokers, two large randomised trials found it INCREASED lung cancer and death.
Caffeine
Probably helpsBlocks adenosine receptors to boost alertness, reaction time, and endurance — an umbrella review of 21 meta-analyses found it ergogenic for endurance, strength and power.
Melatonin
Likely helpsRegulates the circadian clock to reduce sleep onset time — most effective at low doses (0.3-1mg) for jet lag and rhythm disorders.
Explore: Best supplements for Focus, Memory & Mood
Reviewed by Dr. Baher Al Hakim · Last reviewed July 2026 · evidence from 21 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research